Additional Paid-In Capital
Guardant Health Additional Paid-In Capital increased by 1.1% to $2.93B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 18.5%, from $2.47B to $2.93B. Over 5 years (FY 2020 to FY 2025), Additional Paid-In Capital shows an upward trend with a 8.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates successful capital raises or the issuance of equity-based compensation, signaling the company's ability to attract investment or reward talent.
Detailed definition
This represents the amount of capital received from shareholders in excess of the par value of the issued shares. It is...
Peer comparison
Commonly high for biotech companies that frequently issue equity to fund extensive R&D and clinical trial pipelines.
additional_paid_in_capitalHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.6B | $1.63B | $1.66B | $1.68B | $1.7B | $1.72B | $1.74B | $1.76B | $2.17B | $2.19B | $2.3B | $2.33B | $2.36B | $2.41B | $2.44B | $2.47B | $2.52B | $2.56B | $2.9B | $2.93B |
| QoQ Change | — | +1.8% | +1.9% | +1.5% | +1.3% | +0.7% | +1.5% | +1.2% | +23.0% | +0.9% | +5.3% | +1.1% | +1.4% | +2.0% | +1.4% | +1.2% | +1.8% | +1.8% | +13.2% | +1.1% |
| YoY Change | — | — | — | — | +6.7% | +5.5% | +5.1% | +4.8% | +27.4% | +27.5% | +32.3% | +32.1% | +8.9% | +10.1% | +6.1% | +6.1% | +6.5% | +6.2% | +18.7% | +18.5% |
Additional Paid-In Capital at Other Companies
Frequently Asked Questions
- What is Guardant Health's additional paid-in capital?
- Guardant Health (GH) reported additional paid-in capital of $2.93B in Q1 2026.
- How has Guardant Health's additional paid-in capital changed year-over-year?
- Guardant Health's additional paid-in capital increased by 18.5% year-over-year, from $2.47B to $2.93B.
- What is the long-term trend for Guardant Health's additional paid-in capital?
- Over 5 years (2020 to 2025), Guardant Health's additional paid-in capital has grown at a 8.8% compound annual growth rate (CAGR), from $1.9B to $2.9B.
- What does additional paid-in capital mean?
- Capital contributed by shareholders above the par value of the stock.